Fortrea vs Ergomed Clinical Research

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/fortrea/medsource

Category	Fortrea	Ergomed Clinical Research
Listed site	cro	cro
Summary	Fortrea is a leading CRO advancing clinical trials through patient-focused clinical solutions that accelerate clinical development and drive trial success.	Ergomed is a specialized CRO with 25+ years of experience delivering oncology, rare disease, and complex clinical trial solutions across all phases globally, backed by a team of 100+ MDs and PhDs.
Services	Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Phase IV / Post-Marketing Clinical Operations Clinical Trial Services Data Management & eClinical Biostatistics & Statistical Programming Medical Writing Pharmacovigilance & Drug Safety Regulatory Affairs Central Laboratory Services US FDA Regulatory Strategy EU EMA Regulatory Strategy Japan PMDA Regulatory Strategy China NMPA Regulatory Strategy Clinical Imaging Core Lab	Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Phase IV / Post-Marketing Clinical Operations US FDA Regulatory Strategy Regulatory Affairs
Modalities	Small Molecule Biologics (Monoclonal Antibodies) Biologics (Other) Cell Therapy Gene Therapy Vaccine	Small Molecule Biologics (Other) Cell Therapy Gene Therapy
Indications	Cardiovascular Metabolic Dermatology Infectious Disease Immunology Nephrology Neurology Oncology Ophthalmology Rare Disease Respiratory Women's Health Gastroenterology	Oncology Rare Disease
Locations	Global operations, United States Headquarters, Durham, NC, United States Dallas, Dallas, TX, United States Daytona Beach, Daytona Beach, FL, United States Madison, Madison, WI, United States Sydney, Sydney, NSW, Australia Beijing, Beijing, China Chengdu, Chengdu, Sichuan, China Dalian, Dalian, Liaoning, China Guangzhou, Guangzhou, China Hangzhou, Hangzhou, Zhejiang, China Hong Kong, Hong Kong, China Nanjing, Nanjing, Jiangsu, China Shanghai, Shanghai, China Seoul, Seoul, South Korea Taipei, Taipei, Taiwan Tokyo, Tokyo, Japan Raanana, Raanana, Israel Istanbul, Istanbul, Turkey Bogotá, Bogotá, Colombia Buenos Aires, Buenos Aires, Argentina Lima, Lima, Peru Mexico City, Mexico City, CDMX, Mexico Santiago, Santiago, Chile São Paulo, São Paulo, SP, Brazil Centurion, Centurion, Gauteng, South Africa Clinical Research Unit, Dallas, TX, United States Clinical Research Unit, Daytona Beach, FL, United States Clinical Research Unit, Madison, WI, United States Office, São Paulo, SP, Brazil Office, Mexico City, CDMX, Mexico Office, Buenos Aires, Argentina Office, Santiago, Chile Office, Lima, Peru Office, Bogotá, Colombia Office, Centurion, Gauteng, South Africa Office, Sydney, NSW, Australia Office, Beijing, China Office, Shanghai, China Office, Guangzhou, China Office, Chengdu, Sichuan, China Office, Dalian, Liaoning, China Office, Hangzhou, Zhejiang, China Office, Nanjing, Jiangsu, China Office, Hong Kong, China Office, Tokyo, Japan Office, Seoul, South Korea Office, Taipei, Taiwan Office, Raanana, Israel Office, Istanbul, Turkey Office, Herzliya, Israel Herzliya, Raanana, Israel Herzliya, Herzliya, Israel Office, Hong Kong, Hong Kong	Headquarters, Raleigh, North Carolina, United States Operational Hub, Boston, Massachusetts, United States
Certifications	cGMP · Identifier: In-clinic cGMP Pharmacies FDA · Identifier: cGMP	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.